Profile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapy
about
Dysfunctional mTORC1 Signaling: A Convergent Mechanism between Syndromic and Nonsyndromic Forms of Autism Spectrum Disorder?New insights into the pathogenesis and prevention of tuberous sclerosis-associated neuropsychiatric disorders (TAND).Presentation and Diagnosis of Tuberous Sclerosis Complex in Infants.mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases
P2860
Profile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapy
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Profile of everolimus in the t ...... review of its place in therapy
@ast
Profile of everolimus in the t ...... review of its place in therapy
@en
Profile of everolimus in the t ...... review of its place in therapy
@nl
type
label
Profile of everolimus in the t ...... review of its place in therapy
@ast
Profile of everolimus in the t ...... review of its place in therapy
@en
Profile of everolimus in the t ...... review of its place in therapy
@nl
prefLabel
Profile of everolimus in the t ...... review of its place in therapy
@ast
Profile of everolimus in the t ...... review of its place in therapy
@en
Profile of everolimus in the t ...... review of its place in therapy
@nl
P2860
P3181
P356
P1476
Profile of everolimus in the t ...... review of its place in therapy
@en
P2093
David N. Franz
Jamie Capal
P2860
P304
P3181
P356
10.2147/NDT.S91248
P407
P577
2016-08-25T00:00:00Z